REPLIGEN CORP cotiza a 173.88 USD y tiene una capitalización bursátil de $11.0B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.54 | $0.48 | $0.49 |
| Estimado | $0.46 | $0.45 | $0.39 | $0.44 |
| Sorpresa | — | +20.0% | +23.1% | +11.4% |
| Métrica | RGEN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 52.3% | 57.0% | -4.7% |
| Operating Margin | 7.5% | -38.6% | +46.1% |
| Net Margin | 6.6% | -33.6% | +40.2% |
| FCF Margin | 12.7% | -13.9% | +26.6% |
| ROE | 2.3% | -40.4% | +42.7% |
| ROA | 1.7% | -32.0% | +33.7% |
| Current Ratio | 8.37 | 2.84 | +5.53 |
| Debt / Equity | 0.26 | 0.28 | -0.02 |